Multiple Bacterial Proteins

The phrase "Multiple Bacterial Proteins" refers broadly to various proteins found within bacterial cells and does not specify any single protein, gene, or defined molecular entity. In biomedical research or drug discovery, proteins are considered therapeutic targets when identified specifically by gene, function, or protein family (such as "DNA gyrase," "Penicillin-binding protein," or "Ribosomal subunit S12") rather than as bulk categories[1][7]. Many classes of bacterial proteins serve as targets for antibiotics and other therapeutics, but each is defined by its unique structure, sequence, and role in bacterial physiology or virulence (such as transporters, enzymes, toxins, or structural proteins)[2][3]. The use of "Multiple Bacterial Proteins" is too vague and lacks the specificity required for database curation, target validation, or mechanistic description in drug development contexts. If a multi-target or broad-based antimicrobial strategy is under discussion (e.g., mAbs or drugs targeting commonly conserved bacterial components), these still rely on defined lists of protein targets rather than an unspecified set[3][7]. Therefore, this name should be replaced with specific protein names or well-characterized protein families.